Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Opko Health Inc (OPK)

Opko Health Inc (OPK)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
EMA Accepts Marketing Application for Somatrogon to Treat Pediatric Patients with Growth Hormone Deficiency

Pfizer Inc. (NYSE: PFE) and OPKO Health Inc. (NASDAQ: OPK) announced today that the European Medicines Agency (EMA) has validated for review the Marketing Authorization Application (MAA) for somatrogon,...

PFE : 33.81 (+0.90%)
OPK : 4.50 (-2.60%)
Medical And Diagnostic Laboratory Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030

Reportlinker.com announces the release of the report "Medical And Diagnostic Laboratory Services Global Market Report 2021: COVID 19 Impact and Recovery to 2030" - https://www.reportlinker.com/p06027722/?utm_source=GNW...

OPK : 4.50 (-2.60%)
SKHCF : 24.7240 (+0.15%)
Enormous Growth of Global Prostate Cancer Diagnostics Market | Including Top Players like Abbott, MDxHealth, Genomic Health, 3D Signatures, OPKO Health, INC., Siemens Healthcare GmbH, DiaSorin S.p.A, F. Hoffman La Roche Ltd

 

DXD.VN : 0.040 (unch)
GHDX : 63.44 (-0.69%)
OPK : 4.50 (-2.60%)
SIEGY : 79.7500 (+1.79%)
New York State Partners with BioReference Laboratories to Spearhead the NY Forward COVID-19 Rapid Test Program to Help Reopen the New York Economy

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), announced its participation in the NY Forward Rapid Testing Program and opened eight locations offering COVID-19...

OPK : 4.50 (-2.60%)
OPKO Health (OPK) Q4 Earnings and Revenues Beat Estimates

OPKO Health's (OPK) fourth-quarter results benefit from strength in diagnostics.

ANGO : 21.11 (+0.14%)
HOLX : 72.33 (-3.33%)
ABT : 120.11 (-1.98%)
OPK : 4.50 (-2.60%)
OPKO Health (OPK) Q4 Earnings and Revenues Surpass Estimates

OPKO Health (OPK) delivered earnings and revenue surprises of 25.00% and 13.41%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

OPK : 4.50 (-2.60%)
OPKO Health: 4Q Earnings Snapshot

MIAMI (AP) _ Opko Health Inc. (OPK) on Thursday reported fourth-quarter net income of $32.3 million, after reporting a loss in the same period a year earlier.

OPK : 4.50 (-2.60%)
OPKO Health Reports 2020 Fourth Quarter Business Highlights and Financial Results

OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended December 31, 2020.

OPK : 4.50 (-2.60%)
OPKO Health (OPK) to Report Q4 Earnings: What's in Store?

OPKO Health's (OPK) fourth-quarter results are likely to reflect solid performance from Services and Products segment and RAYALDEE.

XRAY : 59.32 (+0.08%)
COO : 383.01 (-1.27%)
OPK : 4.50 (-2.60%)
OPCH : 18.98 (-2.87%)
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021

OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended December 31, 2020, as well as discuss financial guidance, after the close of the U.S. financial...

OPK : 4.50 (-2.60%)
New Drug Application Submitted to PMDA in Japan for Somatrogon, to Treat Pediatric Patients with Growth Hormone Deficiency

OPKO Health, Inc. (NASDAQ: OPK) announced today that its partner, Pfizer Japan Inc., submitted a New Drug Application (NDA) to the Ministry of Health, Labour, and Welfare in Japan for somatrogon, a long-acting...

OPK : 4.50 (-2.60%)
OPKO Health's GeneDx Adds Repeat Expansion Analysis Genetic Tests for Diagnosis of Spinocerebellar Ataxia (SCA), Friedreich Ataxia, and Other Common Forms of Hereditary Ataxia

, /PRNewswire/ -- GeneDx, Inc., a wholly owned subsidiary of BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today launched several new genetic tests, including repeat expansion...

OPK : 4.50 (-2.60%)
OPKO Health's BioReference Laboratories Team-up with the National Basketball Association and National Hockey League to Provide Players and Staff with COVID-19 Testing

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced COVID-19 testing agreements for players and officials, as well as team and league staff for the...

OPK : 4.50 (-2.60%)
OPKO Health's (OPK) BioReference Extends Digital Health Access

OPKO Health's (OPK) BioReference introduces an in-home, fully-integrated digital platform providing access to diagnostic services.

HOLX : 72.33 (-3.33%)
OPK : 4.50 (-2.60%)
ATEC : 16.79 (-0.12%)
CMD : 74.69 (-0.95%)
OPKO Health's BioReference Laboratories Introduces Scarlet Health™, an In-Home Diagnostic Service to Expand Digital Health Access

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today introduced , an in-home, fully integrated digital platform providing access to on-demand diagnostic...

OPK : 4.50 (-2.60%)
Sian Capital Urges OPKO Health to Address Apparently Misleading 4Q'20 Guidance

Sian Capital, LLC (together with its affiliates, "Sian" or "we"), a sizable stockholder of OPKO Health, Inc. (NASDAQ: OPK) ("OPKO" or the "Company"), today announced that it sent a letter to the Company's...

JPM : 154.14 (+2.75%)
OPK : 4.50 (-2.60%)
OPKO Health (OPK) Outpaces Stock Market Gains: What You Should Know

OPKO Health (OPK) closed the most recent trading day at $4.48, moving +1.82% from the previous trading session.

OPK : 4.50 (-2.60%)
OPKO Health to Present at the 39th Annual J.P. Morgan Healthcare Conference

OPKO Health, Inc. (NASDAQ: OPK) today announced that management will be participating in the 39 Annual J.P. Morgan Healthcare Conference being held virtually on January 11-14, 2021. Management will be...

JPM : 154.14 (+2.75%)
OPK : 4.50 (-2.60%)
OPKO Health's BioReference Laboratories Reports Results of the Largest COVID-19 Public School Testing Program Nationwide

, /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced the results of COVID-19 molecular PCR tests for public schools throughout boroughs, with a positivity...

OPK : 4.50 (-2.60%)
OPKO Health's (OPK) BioReference Starts Fan Testing Program

OPKO Health's (OPK) BioReference commences mandatory, large-scale COVID-19 testing programs for fans for AFC Division Wild Card playoff game.

MCK : 171.56 (-1.24%)
MMSI : 55.00 (-0.47%)
PDCO : 29.96 (-7.42%)
OPK : 4.50 (-2.60%)

Van Meerten Stock Picks

5 Great Small Caps
Summary 100% technical buy signals.
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar